agilon health, inc.
AGLNYSEHealthcare · Services-Misc Health & Allied Services, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B |
| Operating income | −$463.2M | −$292.1M | −$232.1M | −$105.4M | −$372.2M | −$56.7M |
| Net income | −$391.3M | −$260.2M | −$262.6M | −$106.6M | −$406.5M | −$60.1M |
| Total assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B | $446.4M |
| Total liabilities | $1.14B | $1.26B | $1.08B | $656.9M | $494.7M | $421.6M |
| Equity | $126.7M | $471.0M | $661.8M | $1.04B | $1.09B | −$284.7M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 412.3M | 409.5M | 413.1M | 401.2M | 400.1M | 249.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −7.8%
- Net margin
- −6.6%
- Return on equity
- −308.8%
- Return on assets
- −30.8%
- Return on capital (ROCE)
- −237.8%
- Liabilities / assets
- 90.0%
- Debt / equity
- 9.03×
- Book value / share
- $0.31
- Revenue growth (YoY)
- −2.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -7.30distress
- Accruals / assets
- −22.5%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Aqr Capital Management LlcPassive (13G)May 14, 2026
- Goldman Sachs Group IncPassive (13G)May 13, 2026
- Vanguard Group IncPassive (13G)Jan 30, 2026
- North Peak Capital Management, LlcPassive (13G)Nov 13, 2025
- Fmr LlcPassive (13G)Nov 5, 2025
- Capital World InvestorsPassive (13G)Sep 5, 2025
- Capital International InvestorsPassive (13G)Aug 13, 2025
- Wellington Management Group LlpPassive (13G)May 12, 2025
- Morgan StanleyPassive (13G)May 5, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Gertsch TimothyOfficer — Chief Accounting Officer | May 24, 2026 | Tax withholding | 8 | $86.39 |
| O'Rourke Timothy PatrickOfficer — CEO & President | May 7, 2026 | Grant | 120,000 | $0.00 |
| Zamore DeniseOfficer — Chief Legal Officer | Apr 14, 2026 | Tax withholding | 20 | $22.68 |
| Venkatachaliah GirishOfficer — Chief Technology Officer | Apr 14, 2026 | Tax withholding | 96 | $22.68 |
| Gertsch TimothyOfficer — Chief Accounting Officer | Apr 14, 2026 | Tax withholding | 25 | $22.68 |
| Shaker BenjaminOfficer — Chief Markets Officer | Apr 14, 2026 | Tax withholding | 104 | $22.68 |
| Schwaneke Jeffrey A.Officer — Chief Financial Officer | Apr 1, 2026 | Tax withholding | 1,662 | $9.75 |
| Shaker BenjaminOfficer — Chief Markets Officer | Apr 1, 2026 | Tax withholding | 1,664 | $9.75 |
| Gertsch TimothyOfficer — Chief Accounting Officer | Apr 1, 2026 | Tax withholding | 266 | $9.75 |
| Venkatachaliah GirishOfficer — Chief Technology Officer | Apr 1, 2026 | Tax withholding | 480 | $9.75 |
| Zamore DeniseOfficer — Chief Legal Officer | Apr 1, 2026 | Tax withholding | 1,024 | $9.75 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 639,741 | 1.0 | -19.2% |
| Apr 30, 2026 | 791,524 | 1.9 | -20.9% |
| Apr 15, 2026 | 1.0M | 2.3 | -26.3% |
| Mar 31, 2026 | 1.4M | 7.1 | -94.9% |
| Mar 13, 2026 | 26.7M | 5.4 | +8.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Director / officer change · Regulation FD disclosureApr 27, 2026
- Modified shareholder rights · Amended charter or bylawsMar 30, 2026
- Shareholder vote · Other material eventMar 18, 2026
- Results of operations · Regulation FD disclosureFeb 25, 2026
- Entered a material agreement · New financial obligationFeb 12, 2026
- Director / officer changeJan 7, 2026
- Delisting / listing-standard notice · Regulation FD disclosureNov 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.